Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Nanocurcumin as Adjuvant Therapy for Anogenital Warts
NCT06281353Phase 3Completed
- Sponsor
- Universitas Indonesia
- Start
- Aug 2022
- Primary completion
- Sep 2023
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nanocurcumin in anogenital warts, sponsored by Universitas Indonesia. Started Aug 2022; status: completed.
02
Drugs
nanocurcumin
03
Conditions
anogenital warts
Beyond the preview
Go deeper on NCT06281353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06281353.